DOI:
10.1055/s-00000140
Pädiatrie up2date
LinksClose Window
References
Turner D, Wolters VM, Russell RK et al.
Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel disease.
J Pediatr Gastroenterol Nutr 2013;
56: 492-497
Access:
We do not assume any responsibility for the contents of the web pages of other providers.